ANI Pharmaceuticals (ANIP)

[LordDarley]

My guess with numbers like this is that they will need another capital raise, in spite of the brave talk. Guggenheim bought most of the last one at $50 and spread it into mutual funds they manage, probably in small enough doses so as not to trigger complaints. In exchange they got a 6 month exclusive, and loyalty after that, for future capital raising transactions.

Amazing that Wall Street can get away with shennanigans like this, but how smart does ANIP look to have raised money at $50/share. Pretty smart.

And how smart do we bagholders look now not to have sold at $40+?

I know, Corti is going to change the world and we have the world class team, etc., etc. Bullshit.